A case of pheochromocytoma was discovered incidentally during long-term hemodialysis for chronic renal failure due to acquired cystic kidney disease. A 52-year-old male patient was examined for weight loss of 3 kg during over a period of 3 months. Abdominal computed tomography (CT) revealed a left adrenal mass (3.0 cm in size). Plasma adrenaline and noradrenaline were increased to 521 pg/ml and 1,341 pg/ml, respectively, and the metoclopramide provocative test was positive. Further, in the scintiscan using 123I-metaiodobenzylguanidine (MIBG), an accumulation of the radionuclide in the left adrenal tumor region was confirmed. The patient is currently under observation and conservative treatment due to the possible occurrence of arterial hypotension after resection of the tumor, and to lesser possibility of the malignancy. (Internal Medicine 36: 403-407, 1997) 
Introduction
Pheochromocytomais one of the three major endocrine causes of hypertension, together with primary aldosteronism and Cushing's syndrome. With the rapid advances in imaging techniques such as computed tomography (CT) scanning, magnetic resonance imaging (MRI), radionuclide scanning and arteriography, and their wide use for the detection of the endocrine tumors, the number of case reports of pheochromocytoma in Japan (1, 2) has increased in recent years to 80 to 90 cases per year, compared with an average of40 cases per year in the 2 decades before the early 1980s. Moreover, it is noteworthy that from A to ll% of the operated cases among the adrenal masses incidentally discovered (adrenal incidentaloma), are pheochromocytomas (3). Therefore, the measurement of catecholamine and its metabolites is indispensable to determine whether the incidentalomas are hormonally functional or not, even whenthe patient has no symptoms or signs characteristic of pheochromocytoma.
Recently we encountered a patient on long-term hemodialysis due to acquired cystic kidney disease in whoma pheochromocytomawas discovered incidentally. Because this is an extremely rare case, we wish to present our case and emphasize the importance of screening of endocrinopathy by means of hormone assays combined with imaging techniques in patients on long-term hemodialysis.
Case Report
A 52-year-old male patient with acquired polycystic kidney disease which developed secondary to glomerulonephritis, on long-term hemodialysis (3 times a week) for the past 20 years, was examined for weight loss of 3 kg during the 3 previous months. During the years of hemodialysis his systolic and diastolic blood pressure ranged from 160-170/70-90 mmHg and 120-130/60-80 mmHgbefore and after dialysis, respectively, without use of any antihypertensive drug. A paroxysmal hypertension of more than the above-mentioned upper levels had not been noted, except for two episodes of transient postdialysis rise of blood pressure. Noother relevant symptomsor signs suggestive of pheochromocytoma were observed. The routine laboratory tests are listed in with homogenous radiodensity (Fig. 1 ). Plasma adrenaline (AD), noradrenaline (NA) and dopamine (DA) were found to be increased to 521 pg/ml (normal: <100 pg/ml), 1,341 pg/ml (normal: 100-450 pg/ml) and 58 pg/ml (normal: <20 pg/ml), respectively. Further the metoclopramide provocative test in- catecholamines, that is, from the basal value of 521 pg/ml to 959 pg/ml for ADand 790 pg/ml to 5,691 pg/ml for NA at the maximumvalues respectively. According to Yamayaet al, the metoclopramide test is judged as positive in a case when the value of increment (maximum value after injection of metoclopramideminus basal value) exceeds the meanvalue plus 4-fold the standard deviation (SD) of the non-pheochromocytoma group (4). In the non-pheochromocytoma group, the mean value plus 4 SD is 37 mmHg for systolic blood pressure, 1 8 1 pg/ml for ADand 226 pg/ml forNA. Howeverthey said that 25 mmHg(mean plus 3 SD) for systolic bloodpressure is ahigh enough value for diagnosis. In the present case, in scintiscan using 1 23I-MIBG, an accumulation of the radionuclide in the left adrenal tumor region was confirmed (Fig. 2) . The plasma catecholamine concentration in the left adrenal venous plasma was remarkably high ( Table 1) . Analyses of the RET protooncogene revealed no mutation in exons 10, 1 1 and 16. 
Discussion
The occurrence of pheochromocytoma in patients on longterm hemodialysis has been considered to be extremely rare (5-16) ( Table 2) . In general, patients with end-stage renal failure (ESRF) are often complicated with hypertension which may sometimesfluctuate and transiently rise after hemodialysis. Therefore, it is important to be cautious in the evaluation of the signs and symptomssuggestive of pheochromocytomaand to analyze for an excessive secretion of catecholamine. Recently, Bravo ( 17) emphasized that the determination of the combination of resting plasma catecholamines (adrenaline plus noradrenaline) and total urinary metanephrines is recommendable as an appropriate biochemical test for the diagnosis of pheochromocytoma. Regarding the demonstration of excessive secretion of catecholamines, one problem is that patients with ESRFare anuric and therefore wecan only rely uponthe assays of plasma adrenaline and noradrenaline. In patients on longterm hemodialysis, plasma noradrenaline has been reported to be almost consistently elevated. Stumvoll et al (15) described that in a patient on long-term hemodialysis a plasma noradrenaline concentration of greater than a 3-fold elevation compared with normal controls, should raise the suspicion of pheochromocytoma.In the present case, the plasma noradrenaline concentration was approximately 3-fold the upper value of normal controls. Moreover, the provocation test by metoclopramide gave a positive result.
The diagnostic problem in a case in which the determination of plasma catecholamine concentration gives an equivocal rise, not exceeding a 3-fold value, however, can be solved by localizing techniques for pheochromocytoma, in particular, 131I-metaiodobenzylguanidine (MIBG) scanning which has a specificity of 100%(17). In the present case, an adrenal mass was incidentally discovered by CT which was carried out as a series of examinations to explore the possible causes for weight loss. Then the tumor was found to be functional by the marked Regarding the treatment, resection of the tumor by operation is usually considered the first choice if possible. In fact, numerous previously reported cases of pheochromocytoma with
ESRFon hemodialysis therapy were operated successfully (5-
10, 12-16).
However, the present case had little complaint except for weight loss. The systolic blood pressure usually decreased to 120-130 mmHg,sometimes below 100 mmHg,at the end of hemodialysis therapy, so that the extra-renal organ damage was not so severe (ocular fundus: Scheie H^, cardiothoracic ratio: 50-52%). Therefore we were rather concerned about the possible occurrence of arterial hypotension after resection of the tumor. It is well known that many patients on long-term hemodialysis treatment suffer from hypotension. Daul et al ( 1 8) reported that increased plasma noradrenaline levels with longer duration of hemodialysis may induce a-adrenoceptor down-regulation and the resulting reduction in a-adrenoceptor responsiveness to ocadrenergic stimuli might be an important cause of arterial hypotension in patients on long-term hemodialysis treatment.
Because of the lengthy hemodialysis treatment reaching 20
years in the present case, it is more likely that the patient may suffer from difficult-to-control hypotension during hemodialysis therapy if the tumor is resected. Also, for low possibility of a malignant tumor, at present we are following-up the patient conservatively. Six months after the diagnosis, his body weight did not change at all and abdominal CTrevealed no enlargement of the tumor size. However,if the tumor size increases and the blood pressure becomes higher, surgical operation should be considered. 3) Ito Y. Clinical feature ofadrenal incidentaloma. EndocrSurg6: 236, 1989 (in Japanese). 
